Rosenberg, Anna http://orcid.org/0000-0003-1456-7991
,
Coley, Nicola
Soulier, Alexandra
Kulmala, Jenni
Soininen, Hilkka
Andrieu, Sandrine
Kivipelto, Miia
Barbera, Mariagnese
Funding for this research was provided by:
Academy of Finland (291803)
VTR Kuopion Yliopistollinen Sairaala (5772815)
Agence Nationale de la Recherche (ANR-14-JPPS-0001-02)
Bundesministerium für Bildung und Forschung (FKZ01ED1509)
ZonMw (733051041)
Vetenskapsrådet (529-2014-7503)
Stockholm Sjukhem Foundation
Alzheimerfonden
Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
Seventh Framework Programme (305374)
EU Joint Programme – Neurodegenerative Disease Research
Suomen Kulttuurirahasto
Finnish Brain Foundation
Emil Aaltosen Säätiö
Article History
Received: 5 November 2019
Accepted: 26 February 2020
First Online: 12 March 2020
Ethics approval and consent to participate
: Ethical approvals for the HATICE trial and the ACCEPT-HATICE sub-study were obtained from the Ethics Committee of the Hospital District of Northern Savo in Finland (10/06/2014 ref. 35/2014; 15/03/2016 ref. 116/2016), the Medical Ethical Committee of the Academic Medical Center in the Netherlands (26/06/2014 ref. 2014_126; 06/10/2015 ref. 2014_126), and the Comité de Protection des Personnes (CPP) Sud Ouest et Outre Mer in France (24/09/2014 ref. 2014-A01287–40; 25/11/2015 ref. 2014-A01287–40). All participants provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.